Axogen (AXGN) Share-based Compensation (QoQ) (2010 - 2026)
Axogen (AXGN) Share-based Compensation (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Axogen | 2.42 Bn | 2.31 Bn | 50.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.14% |
| Mar 31, 2026 | -47.17% |
| Dec 31, 2025 | 206.25% |
| Sep 30, 2025 | 4.95% |
| Jun 30, 2025 | 77.66% |
| Mar 31, 2025 | -5.43% |
| Dec 31, 2024 | -38.53% |
| Sep 30, 2024 | 28.08% |
| Jun 30, 2024 | -0.31% |
| Mar 31, 2024 | 195.33% |
| Dec 31, 2023 | -72.05% |
| Sep 30, 2023 | -11.93% |
| Jun 30, 2023 | 82.46% |
| Mar 31, 2023 | -28.89% |
| Dec 31, 2022 | 7.92% |
| Sep 30, 2022 | -21.61% |
| Jun 30, 2022 | 83.35% |
| Mar 31, 2022 | 77.47% |
| Dec 31, 2021 | -48.16% |
| Sep 30, 2021 | -23.50% |